TRANSFER 2000 IU INJECTION

Transfer 2000IU injection contains active components like Recombinant Human erythropoietin ALFA/Epo. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). The drug treats anemia due to chronic kidney diseases (CKD), chemotherapy for cancer, or HIV treatment using zidovudine. It also reduces the requirement for transfusions of red blood cells for patients at risk of losing blood because of planned surgery and other surgical procedures.
Transfer 2000IU injection should not be used by patients who have an allergy to any component of it, uncontrolled hypertension, active thrombotic microangiopathy (TMA), Pure red cell cancer (PRCA), uncontrolled seizures, and pregnancy or lactation. It is also recommended to use it cautiously in patients who have a background of bleeding clots, heart disease, kidney disease, stroke, liver diseases, thalassemia, sickle cell anemia(SCA), myelodysplastic syndrome, cancer, or leukemia. It should not be used for children under 18 when the benefits outweigh the risks. Seniors who are taking this medication must be monitored closely for any adverse negative effects. Before you begin this treatment, consult your physician about the potential dangers and benefits of the Transfer 2000IU injection.